UTHSCSA - Faculty Profiles

Search All | Profile | Publications | Grants | Faculty Index

Lam, Yui-Wing Francis

Graduate School of Biomedical Sciences
Pharmacology
(210) 567-8319
lamf@uthscsa.edu

As a tenured Professor of Pharmacology, my unique professional education and expertise are in pharmacokinetics, pharmacodynamics, and pharmacogenomics. I had provided patient care, therapeutic and pharmacokinetic consultations. As the director of an accredited clinical laboratory for therapeutic drug monitoring, I had successfully integrated the laboratory and clinical services for provision of patient care. Currently I am the course director and primary faculty for seven pharmacology and therapeutics related courses at UTHSCSA, and also participated in ten team-taught courses. I am the recipient of multiple teaching excellence awards including the 2018 Minnie Stevens Piper Professor, the 2015 University of Texas System Regents` Outstanding Teaching Award, and the 2016 Presidential Teaching Excellence Award. I was inducted into the University of Texas Kenneth I. Shine Academy of Health Science Education in 2017. I had also served as a Faculty Senator for the UTHSCSA Faculty Senate, Chair of Pharmacology COGS and deputy-director of the Physiology and Pharmacology Discipline of the IBMS program of the Graduate School of Biomedical Science

Appointments Education Expertise Teaching Publications Grants

9/2010 - Present	Professor of Pharmacology	The University of Texas Health Science Center at San Antonio, Pharmacology, San Antonio, TX
9/1997 - Present	Associate Professormof Medicine	The University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX
9/1995 - Present	Clinical Associate Professormof Pharmacy	The University of Texas at Austin, College of Pharmacy, Austin, TX

Date	Description	Institution	# Students
7/2019 - Present	PHAR 5023 Drug Discovery and Development		6 students
Co-Course Director - The Drug Discovery and Development is a new course developed jointly with faculty member from University of Texas at San Antonio. The course provides students with an understanding of the overall process of drug discovery and development. It covers the basic principles of how new drugs are discovered, how drugs interact with their biological targets, application of medicinal chemistry in lead optimization, and focused discussion on drug development in specific therapeutic areas.
1/2019 - Present	Advanced Head & Neck/Oral	The University of Texas Health Science Center	100 students
DHHD 6009 is one of the 10 new courses within the SOD new Human Health and Disease Track, of which I am the Co-Track Leader.
8/2018 - Present	Renal, Gastrointestinal and Liver	The University of Texas Health Science Center	100 students
Co-Course Director - DHHD 6006 is one of the 10 new courses within the SOD new Human Health and Disease Track, of which I am the Co-Track Leader. I served as the co-course director for this course.
7/2018 - Present	Cardiovascular and Pulmonary Systems	The University of Texas Health Science Center	100 students
Co-Course Director - DHHD 6005 is one of the 10 new courses within the SOD new Human Health and Disease Track, of which I am the Co-Track Leader. I served as the co-course director for this course for the AY 2018/2019, and passed on that role when another faculty agreed to serve as course director beginning Fall 2019.
4/2018 - Present	Biological Foundations	The University of Texas Health Science Center	100 students

3/2018 - Present	Periodontium and Pulp	The University of Texas Health Science Center	100 students
DHHD 5003 is one of the 10 new courses within the SOD new Human Health and Disease Track, of which I am the Co-Track Leader.
9/2017 - Present	Craniofacial Complex	The University of Texas Health Science Center	100 students
DHHD 6005 is one of the 10 new courses within the SOD new Human Health and Disease Track, of which I am the Co-Track Leader.
8/2016 - Present	Pharmacological Principles in Physical Therapy	The University of Texas Health Science Center	60 students
Course Director - Student Enrollment: 60. I have been requested by the Department of Physical Therapy, School of Health Professions, to direct the course and be the primary teaching faculty starting Fall 2016. I was previously a lecturer giving a 2-hr lecture for the course between 8/2012 to 8/2013.
6/2016 - Present	PHAR7002
Course Director - The Clinical Practicum in Pharmacology is a formal elective course for graduate students in the Physiology and Pharmacology Discipline that provides students with focused first-hand exposure to therapeutics and clinical practice. The course incorporates case-based scenarios and a clinical experience in an area relevant to the student?s area of research.
1/2015 - Present	Pharmacology II	The University of Texas Health Science Center	45 students
Course Director - Course Director and primary course faculty. Student Enrollment: 45
7/2014 - Present	Pharmacology I	The University of Texas Health Science Center	45 students
Course Director - Course Director and primary course faculty. Student Enrollment: 45
9/2012 - Present	CIRC 5007 Fundamentals: Molecules to Medicine		250 students
Student Enrollment: 250
9/2010 - Present	PHM 483-Pharmacotherapeutics I, University of Texas at Austin		106 students
Student Enrollment: 106. The course previously had different course numbers: PHA 665E, PHR 565F, PHR 655E, and PHM 685D prior to 2015. I have been teaching the course since 12/2009.
8/2002 - Present	PGS 381W/PHAR 6020-Molecular and Pharmacological Basis of Therapeutics, UTA and UTHSCSA		5 students
Course Director - Student Enrollment: 5. I designed and implemented this course (previous course number PHR 381W) in 2002 to educate students the emerging role of pharmacogenetics and pharmacogenomics in optimization of drug therapy. The course is also listed as an elective course (PHAR 6020) for UTHSCSA pharmacology graduate students. Over the years, I have introduced different components to the basic didactic lecture format, including laboratory sessions, student debates on controversial topics, student presentations, faculty-led discussion, and field trips to clinical laboratories. This course is also part of the curriculum offering of the Joint Ph.D. degree in Translational Science at UTHSCSA, University of Texas at Austin, and University of Texas at San Antonio.
8/2000 - Present	Clinical Pharmacology	The University of Texas Health Science Center	12 students
Student Enrollment: 12.
8/1993 - Present	Prin of Pharmacology I	The University of Texas Health Science Center	9 students
Student Enrollment: 9. Between 1988 to 1992, I was also involved in teaching Advanced Pharmacology, which was the "predecessor" of Principles of Pharmacology.

Abstract

Chapa I, J Hensler F Lam, L McManus, A Giuffrida, E Russell-McKenzie, AL DePass. Examining outcomes of the Voelcker Biomedical Research Academy (VBRA) for high school students; 2017 Mar. (Proceedings of Understanding Interventions That Broaden Participation in Science Careers).

Wang Chen-Pin, Kuhn John, Lam Yui-Wing F, DeFronzo Ralph A, Alkhouri Naim. The Use of Metformin Reduces the Burden Of Chronic Liver Diseases in Hispanic Veterans with Type 2 Diabetes; 2017 Jan. (Hepatology; vol. 66, no. 1).

Macy B, Lam YWF, Lam A. Comparing the Pharmacokinetics of Rectally Administered Phenobarbital Tablets in Microenema Form versus Suppository; 2016 Jan. (Journal of Pain and Symptom Management; vol. 51, no. 2).

Wang C, Lehman D, Lam Y, Kuhn J, Mahalingam D, Weitman S, Hernandez J, Lorenzo C, Downs J, Espinoza S, Ramirez A. Metformin reduces prostate cancer disparity in men with type 2 diabetes?; 2015 Jun. (Diabetes; vol. 64, no. S1).

Book Chapter

Lam YF. Role of Pharmacogenomics in Diabetes. In: Lam YWF, Duggirala, R, Jenkinson C, Arya, R. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. Lam YWF, Scott S (ed). 2nd edition. p. 247-269.

Lam YF. Economic Evaluation of Phamacogenomic Testing: Lessons from Psychiatric Pharmacogenomics. In: Lam YWF. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. Lam YWF, Scott S (ed). 2nd edition. 2019. p. 385-394.

Lam YF. Pharmacogenomics in Psychiatric Disorders. In: Lam YWF, Someya T. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. Lam YWF, Scott S (ed). 2nd edition. 2019. p. 247-269.

Lam YF. Pharmacokinetic, Pharmacodynamic, and Clinical Implications. In: Pharmacogenomics. In: Lam YWF. Challenges and Opportunities in Therapeutic Implementation. Lam YWF, Scott S (ed). 2nd edition. 2019. p. 1-53.

Lam YWF. Translating Pharmacogenomic Research to Therapeutic Potentials. In: Lam YWF. Challenges and Opportunities in Therapeutic Implementation. Lam YWF, Scott S (ed). 2nd edition. 2019. p. 181-225.

Lam Y. Pharmacogenomics in Cancer Therapeutics. In: Lam YWF, Scott, SA. Challenges and Opportunities in Therapeutic Implementation. Lam YWF, Scott S (ed). 2nd edition. 2019. p. 123-132.

Cavallari L, Lam YWF. Pharmacogenetics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (Editors). Pharmacotherapy: A Pathophysiologic Approach, 10th edition. New York, New York: McGraw-Hill; 2017.

Lam YWF. Clinically Significant Drug Interactions With Psychopharmacological Agents: Antidepressants. In: Jann, MW, Penzak S, Cohen L (ed). Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. 2016. p. 451-469.

Book/Monograph

Lam YWF, Scott S (editors). Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. 2nd edition 2019.

Journal Article

Wang CP, Kuhn J, Shah DP, Schmidt S, Lam YF, MacCarthy D, Tenner L, Ramirez AG. Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases Cancer Medicine 2019 Apr;8(6):3206-3215.

Hermann R, Lam YWF, Spackman G. True Allergic Reaction to Amide Local Anesthetics such as Lidocaine is Confirmed by Immunologic Testing Texas Dental Journal 2016 Feb;133.

Lam YF, Lam A, Macy B. Pharmacokinetics of Phenobarbital in Micro-enema Via Macy Catheter versus Suppository Journal of Pain and Symptom Management 2016 Jan;51:994-1001.

Wang CP, Lehman D, Lam YWF, Kuhn J, Mahalingam D, Weitman S, Lorenzo C, Downs JD, Stuart EA, Hernandez J, Thompson IM, Ramirez AG . Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type 2 Diabetes Cancer Prevention Research 2016 Jan;9:779-787.

Not Specified

Lam YF. Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications. In: Pharmacogenomics 2019 Jan;:1-53.

Year	Degree	Discipline	Institution
1984	PharmD	Clinical Pharmacy	College of Pharmacy, University of Minnesota Minneapolis , MN
1981		Pharmacy (Graduated with Honors)	School of Pharmacy, University of Bradford West Yorkshire , United Kingdom
	Postdoctoral Fellowship	Pharmacokinetics and Pharmacodynamics	School of Pharmacy and Drug Studies Unit, Univ. of California San Francisco San Francisco , CA
	Residency	Cardiology and Pharmacokinetics	College of Pharmacy, University of Minnesota Minneapolis , MN

Private
Funding Agency	Voelcker Foundation
Title	The Max and Minnie Tomerlin Voelcker Biomedical Research Academy
Status	Active
Period	6/2018 - 5/2022
Role	Co-Principal Investigator
Grant Detail

Faculty

FAQ

Suggestions